Reuters logo
1 年前
BRIEF-Ocular Therapeutix says completes end-of-phase 2 review with FDA for OTX-TP for glaucoma and ocular hypertension
2016年4月27日 / 晚上9点02分 / 1 年前

BRIEF-Ocular Therapeutix says completes end-of-phase 2 review with FDA for OTX-TP for glaucoma and ocular hypertension

1 分钟阅读

April 27 (Reuters) - Ocular Therapeutix Inc

* Says completes end-of-phase 2 review with FDA for OTX-TP for glaucoma and ocular hypertension

* Says based on this review, company intends to initiate first of two phase 3 clinical trials during Q3 of 2016

* Says FDA has stated that it agrees with overall phase 3 clinical development program proposed by ocular Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below